BriaCell Therapeutics Corp.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jul 2020 | — | $-2.7M | — |
| Jul 2021 | — | $27.7M | $57.3M |
| Oct 2021 | — | $1.6M | — |
| Jan 2022 | — | $16.4M | — |
| Apr 2022 | — | $10.0M | — |
| Jul 2022 | — | $10.3M | $41.0M |
| Oct 2022 | — | $10.3M | $37.5M |
| Jan 2023 | — | $-1.3M | $33.5M |
| Apr 2023 | — | $-5.9M | $28.2M |
| Jul 2023 | — | $-3.8M | $21.3M |
| Oct 2023 | — | $2.5M | $13.6M |
| Jan 2024 | — | $-8.3M | $6.2M |
| Apr 2024 | — | $-6.2M | $935.7K |
| Jul 2024 | — | $-2.7M | $862.1K |
| Oct 2024 | — | $3.7M | $5.8M |
| Jan 2025 | — | $3.2M | $5.0M |
| Apr 2025 | — | $11.9M | $12.5M |
| Jul 2025 | — | $17.3M | $10.5M |
| Oct 2025 | — | $9.4M | $2.7M |
| Jan 2026 | — | $30.2M | $29.9M |
| Apr 2026 | — | $23.4M | $6.9M |